Regulatory Submission Writer for Medical Professionals
Draft compliant regulatory submissions for medical devices and pharmaceuticals
What You Can Do
You'll compose regulatory submission documents like Common Technical Documents (CTD), Periodic Safety Updates (PSUR), and Quality Overall Summaries with built-in FDA, EMA, and ICH compliance checks. This skill accelerates document drafting by applying structured templates aligned with regulatory guidelines, reducing revision cycles and ensuring professional-quality submissions. Every generated module is validated for completeness, consistency, and traceability across related sections.
Features
Generates Common Technical Document sections (2.3 Clinical Summary, 2.4 Quality Overall Summary, 3.2 Quality, 3.3 Nonclinical) with module-specific compliance checks and cross-references built in.
Writes Periodic Safety Update Reports (PSUR), Individual Case Safety Reports (ICSR), and Risk Management Summaries with structured adverse event narratives and causality assessments.
Pre-built templates for FDA 21 CFR, EMA common submission format, ICH M4 structure, and PMDA requirements that enforce mandatory sections and formatting standards.
Generates QbD narratives, design space justifications, and critical quality attribute explanations aligned with ICH Q8, Q9, and Q10 expectations.
Automatically links related sections, flags inconsistencies between modules, and ensures all referenced studies, data points, and citations are traceable and accurate.
Converts submissions between regional formats and adjusts terminology, safety coding, and dosing terminology for FDA, EMA, PMDA, Health Canada, and other authorities.
Detects contradictions between clinical safety findings and product labeling, identifies missing justifications, and flags unsupported claims before submission.
Example Output
Example 1: CTD Module 2.3 Excerpt (Clinical Summary)
2.3.2 Pharmacology and Pharmacokinetics
Following single oral doses of 10 mg, [Product] demonstrated peak plasma concentrations within 1–2 hours. The drug exhibits linear kinetics up to 20 mg. Hepatic metabolism accounts for >95% of elimination; renal clearance is minimal. Protein binding is approximately 88%, with no clinically significant interactions in vitro at therapeutic concentrations (Study XYZ-PK-001).
Example 2: PSUR Safety Summary Excerpt
Cardiovascular Disorders (SOC)
Across all clinical and post-marketing data (n=4,521 patient-years), serious cardiovascular events occurred in 1.8% of [Product] patients vs. 1.1% placebo. Atrial fibrillation was the most frequent signal (n=47, temporal relationship: probable; dose-response observed in Study XYZ-304). Proposed risk minimization: label update to Section 4.4 recommending baseline ECG in patients ≥60 years.
Example 3: Quality Overall Summary (QbD Justification)
The target product profile established critical quality attributes: assay (98–102%), related substances (individual ≤0.1%, total ≤0.5%), and dissolution (≥80% at 30 min). The design space was established through DoE across tablet compression force (80–120 bar), binder concentration (3–7%), and API particle size (d90 10–30 μm). Edge-of-design-space batches confirmed QbD model robustness per ICH Q11.
What's Included
- CTD Template Library: Fully customizable templates for all CTD sections (2.3, 2.4, 3.2, 3.3) with pre-populated headings, required subsections, and formatting aligned with eCTD standards.
- Regulatory Requirement Database: Pre-loaded FDA 21 CFR Part 11, EMA Guidelines, ICH M4/Q8/Q9/Q10, and regional safety coding standards (MedDRA, ICSR, CDISC) for automatic validation.
- Compliance Checklist Engine: Interactive checklists for FDA Form 356H, Common Technical Document completeness, and pre-submission QA to prevent missing sections or data gaps.
- Cross-Reference Validator: Automatically links modules, flags contradictions between sections, and ensures consistent terminology and dosing information across all submission documents.
- Example Modules & Redacted Submissions: Real-world module examples from approved NDA/MAA filings (template-ready and annotated) to accelerate your drafting and ensure regulatory best practices.
- Regional Adaptation Guide: Step-by-step instructions for converting eCTD to regional formats, adjusting safety terminology for PMDA/Health Canada, and applying region-specific formatting requirements.
Who It's For
- Regulatory Affairs Manager
- Medical Writer
- Quality Assurance & Compliance Specialist
- Pharmacovigilance Professional
- Regulatory Submission Coordinator
Best For
- CTD Module 2 (Summaries) Composition
- Periodic Safety Updates (PSUR) and ICSR Drafting
- Quality Overall Summary with QbD Narratives
- Pre-submission Package Preparation & Compliance Verification
- Multi-Regional Submission Adaptation (FDA, EMA, PMDA)
You might also like
You can automate the creation of comprehensive, regulatory-compliant Statistical Analysis Plans (SAPs) for clinical trials. The skill generates complete SAP documents with FDA/ICH-aligned sections, performs compliance validation, optimizes statistical methodologies, and ensures consistency with trial protocols—reducing SAP development time from weeks to days.
by hah23255
You can systematically review research protocols against ethical frameworks, regulatory standards, and risk-benefit principles. This skill identifies compliance gaps, assesses risks to human or animal subjects, evaluates scientific merit against potential harms, and generates structured compliance reports that support institutional review board (IRB) decisions and regulatory submissions.
by hah23255
You'll design and optimize observational study protocols from conception through regulatory documentation. The skill guides you through identifying and quantifying confounders, selecting appropriate study designs (cohort, case-control, cross-sectional), implementing bias mitigation strategies, and generating publication-ready protocols that meet regulatory standards.
by hah23255
Design, validate, and refine clinical device trial protocols that meet FDA and ICH regulatory requirements. You'll receive detailed protocol structure, endpoint validation matrices, statistical power analysis, and enrollment strategy recommendations that accelerate patient recruitment while maintaining compliance.
by hah23255
You get expert guidance developing NSF-aligned healthcare research proposals from strategic positioning through final compliance. Claude analyzes your research concept against NSF priorities, structures a competitive narrative, justifies budget allocations, and ensures all compliance requirements (biosketch, data management plans, institutional review) are met. The result is a cohesive, review-ready proposal that increases your chances of NSF funding.
by hah23255
You structure clinical research manuscripts according to IMRaD (Introduction, Methods, Results, Discussion) standards required by peer-reviewed journals. This skill helps you draft sections from raw research notes, polish prose for academic clarity, enforce citation standards, and identify common submission issues before sending to journals. The result is a manuscript ready for peer review with minimal editor feedback.
by hah23255
You can systematically work through complex clinical ethical dilemmas using proven frameworks like the Four Principles approach, principlism, casuistry, and virtue ethics. The skill maps all stakeholders, identifies competing ethical obligations, and generates IRB-ready documentation that prepares you for ethics committee consultations. You'll receive structured analysis, conflict resolution pathways, and compliance recommendations tailored to your specific case.
by hah23255
You can design, validate, and execute statistical analyses for health outcomes research, comparative effectiveness studies, and clinical trials with regulatory rigor. This skill guides you through study design validation, appropriate statistical method selection, data quality assessment, hypothesis testing, and results interpretation aligned with FDA, EMA, and ICH-GCP standards. You'll generate publication-ready analysis plans and ensure your findings meet scientific and regulatory requirements for peer review or submission.
by hah23255